Crigler–Najjar syndrome

From WikiMD

Wellness.png

WikiMD is a free medical encyclopedia moderated by medical professionals and is a reliable source of information on a wide range of health, weight loss and wellness related topics. Who wants to trust their health with amateurs?

Let Food Be Medicine, Medicine Be Food - Hippocrates

Crigler–Najjar syndrome
Classification and external resources
ICD-10E80.5
ICD-9277.4
OMIM218800 606785
DiseasesDB3176
MedlinePlus001127
eMedicinemed/476
MeSHD003414

Crigler–Najjar syndrome or CNS is a rare disorder affecting the metabolism of bilirubin, a chemical formed from the breakdown of red blood cells. The disorder results in an inherited form of non-hemolytic jaundice, which results in high levels of unconjugated bilirubin and often leads to brain damage in infants.

This syndrome is divided into type I and type II, with the latter sometimes called Arias syndrome. These two types, along with Gilbert's syndrome, Dubin–Johnson syndrome, and Rotor syndrome, make up the five known hereditary defects in bilirubin metabolism. Unlike Gilbert's syndrome, only a few hundred cases of CNS are known.

Type I

This is a very rare disease (estimated at 0.6–1.0 per million live births), and consanguinity increases the risk of this condition (other rare diseases may be present). Inheritance is autosomal recessive.

Intense jaundice appears in the first days of life and persists thereafter. Type 1 is characterised by a serum bilirubin usually above 345 µmol/L (310–755) (whereas the reference range for total bilirubin is 2–14 μmol/L).

No UGT1A1 (UDP glucuronosyltransferase 1 family, polypeptide A1) expression can be detected in the hepatic tissue. Hence, there is no response to treatment with phenobarbital[1] (which causes CYP450 enzyme induction). Most patients (type IA) have a mutation in one of the common exons (2 to 5), and have difficulties conjugating several additional substrates (several drugs and xenobiotics). A smaller percentage of patients (type IB) have mutations limited to the bilirubin-specific A1 exon; their conjugation defect is mostly restricted to bilirubin itself.

Before the availability of phototherapy, these children died of kernicterus (bilirubin encephalopathy) or survived until early adulthood with clear neurological impairment. Today, therapy includes

Type II

Type II differs from type I in several aspects:

  • Bilirubin levels are generally below 345 µmol/L (100–430; thus, there is overlap), and some cases are only detected later in life.
  • Because of lower serum bilirubin, kernicterus is rare in type II.
  • Bile is pigmented, instead of pale in type I or dark as normal, and monoconjugates constitute the largest fraction of bile conjugates.
  • UGT1A1 is present at reduced but detectable levels (typically <10% of normal), because of single base pair mutations.
  • Therefore, treatment with phenobarbital is effective, generally with a decrease of at least 25% in serum bilirubin. In fact, this can be used, along with these other factors, to differentiate type I and II.
  • The inheritance pattern of Crigler–Najjar syndrome type II has been difficult to determine but is generally considered to be autosomal recessive.[2]

Differential diagnosis

Neonatal jaundice may develop in the presence of sepsis, hypoxia, hypoglycemia, hypothyroidism, hypertrophic pyloric stenosis, galactosemia, fructosemia, and so on.

Hyperbilirubinemia of the unconjugated type may be caused by

In Crigler–Najjar syndrome and Gilbert syndrome, routine liver function tests are normal, and hepatic histology usually is, too. There is no evidence for hemolysis. Drug-induced case typically regress after discontinuation of the substance. Physiological neonatal jaundice may peak at 85–170 µmol/L and decline to normal adult concentrations within two weeks. Prematurity results in higher levels.

Research

One 10-year-old girl with Crigler–Najjar syndrome type I was successfully treated by hepatocyte transplantation.[3]

The homozygous Gunn rat, which lacks the enzyme uridine diphosphate glucuronyltransferase (UDPGT), is an animal model for the study of Crigler–Najjar syndrome. Since there is only one enzyme working improperly, gene therapy for Crigler Najjar is a theoretical option which is being investigated.[4]

Gunn Rat: Dr. C. H. Gunn discovered a mutant rat in 1934 at the Connaught Laboratory in Toronto, Canada. These rats were jaundiced and the defect was transmitted as an autosomal recessive characteristic. Dr Gunn, a Geneticist, bred them at Connaught and later moved to Summerside, Prince Edward Island, Canada to head up the Canadian Experimental Fox Ranch. Gunn rats are still commercially available today from Harlan, Indianapolis, Indiana. Gunn rats are also available from Japan SLC Inc.. This animal model has been extremely valuable for the development of experimental treatments for this disease.

Eponym

The condition is named for John Fielding Crigler (b. 1919), an American Pediatrician and Victor Assad Najjar (b. 1914), a Lebanese-American Pediatrician.[5][6]

See also

References

  1. Chowdhury, J. R.; Wolkoff, A. W.; Chowdhury, N. R.; Arias, I. M.: "Hereditary jaundice and disorders of bilirubin metabolism." In: Scriver, C. R.; Beaudet, A. L.; Sly, W. S.; Valle, D. (eds.): The Metabolic and Molecular Bases of Inherited Disease. Vol. 2. New York: McGraw-Hill (8th ed.) 2001. Pp. 3063–3101.
  2. synd/86 at Who Named It?

External links

Pediatric glossary of terms | Glossary of medical terms | Dictionary of pediatrics

Table of contents:

.A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M

.N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

# - A

B

C

D

Table of contents:

.A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M

.N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

E

F

G

H

I

J

K

L

Table of contents:

.A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M

.N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

M

N

O

Table of contents:

.A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M

.N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

P

R

S

T

U

V

Table of contents:

.A | .B | .C | .D | .E | .F | .G | .H | .I | .J | .K | .L | .M

.N | .O | .P | .Q | .R | .S | .T | .U | .V | .W | .X | .Y | .Z

W

X

Z

edit 

WikiMD - medicine navigation

W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*

Quick links: Medicine Portal | Encyclopedia‏‎‏‎ | Gray's Anatomy‏‎ | Topics‏‎ |‏‎ Diseases‏‎ | Drugs | Wellness | Obesity‏‎ | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="http://www.wikimd.org/wiki/Crigler%E2%80%93Najjar_syndrome">Crigler–Najjar syndrome</a>

  • Individual results may vary for weight loss from our sponsors.